Search results
Age-Related Macular Degeneration: Putting a Hole in Our World
WebMD· 6 hours agoWhen we’re young, we take our macula for granted. At the center of our retina – the deepest layer of the eye that’s chock-full of photoreceptors and that confers color to our world – the macula ...
EyePoint Pharmaceuticals Q1 2024 Earnings: Revenue Surpasses Estimates Despite Challenges
GuruFocus.com via Yahoo Finance· 3 hours agoThe company utilizes its proprietary Durasert E and Verisome technology platforms to develop...
The American Macular Degeneration Foundation Showc | Newswise
Newswise· 2 days agoNorthampton, MA, May 9, 2024 – Seven scientists supported by the American Macular Degeneration Foundation (AMDF) and studying age-related macular ...
Kyowa Kirin Will Present Pre-Clinical Data at the Association for Research in Vision and...
Char-Koosta News· 2 days agoAge-related macular degeneration (AMD) is a leading cause of severe vision loss for people aged 50 years and older in developed countries worldwide, with ...
Adverum Biotechnologies Reports Q1 2024 Results: A Detailed Look at Financials and Pipeline Progress
GuruFocus.com via Yahoo Finance· 2 hours agoIts flagship product, ADVM-022 (Ixo-vec), aims to revolutionize care for patients with wet age-related macular degeneration (AMD) by ...
These 2 ‘Strong Buy’ Penny Stocks Could Surge Over 400%, Says Oppenheimer
TipRanks via Yahoo Finance· 1 day agoRisk and reward are the yin and yang of stock trading, the two essential yet opposing forces in...
EyePoint Pharmaceuticals’ stock plunges as eye treatment fails to meet trial goal
Market Watch· 4 days agodropped nearly 30% in premarket trading Monday after the company said its experimental...
The most innovative Mother’s Day campaigns from Dove, MoneyGram, DoorDash & more
The Drum· 8 hours agoFrom heartwarming reunions facilitated by DoorDash to MullenLowe planting career opportunities for...
Why Is EyePoint Pharmaceuticals Stock Plummeting On Monday?
Benzinga via Yahoo Finance· 4 days agoOn Monday, EyePoint Pharmaceuticals Inc. (NASDAQ:EYPT) announced the topline results of its Phase 2...
EyePoint tumbles 30% premarket on failed Phase 2 study (NASDAQ:EYPT)
Seeking Alpha· 4 days agoEyePoint (EYPT) stock tumbled nearly 30% in premarket trading Monday after the company said a Phase...